BB Biotech AG

Swiss Stock Exchange BION.SW

BB Biotech AG Market Capitalization on January 14, 2025: USD 2.29 B

BB Biotech AG Market Capitalization is USD 2.29 B on January 14, 2025, a -19.57% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

BB Biotech AG 52-week high Market Capitalization is USD 3.08 B on February 09, 2024, which is 34.74% above the current Market Capitalization.
BB Biotech AG 52-week low Market Capitalization is USD 2.14 B on January 10, 2025, which is -6.55% below the current Market Capitalization.
BB Biotech AG average Market Capitalization for the last 52 weeks is USD 2.53 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Swiss Stock Exchange: BION.SW

BB Biotech AG

CEO	Dr. Daniel Koller Ph.D.
IPO Date	Jan. 4, 2000
Location	Switzerland
Headquarters	Seestrasse 16
Employees	10
Sector	Health Care
Industries Biotechnology Hedge Funds Private Equity

Description

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Key trends

Past 5 years